USD28.23
Orforglipron for obesity treatment in older patients ≥65 years with or without type 2 diabetes: A post hoc subgroup analysis of the ATTAIN-1 and ATTAIN-2 trials - ScienceDirect Treatment:3 Months stuffy nose Pernicious Anemia https://www.americanpeptides.us/media/0ab8cf5de006c980.png Brief assessment
USD28.23
USD29.05
USD23.91